Search
Enter keywords, a title or a report id number below.
Your Search for 'Insurance - Poland - A Snapshot (2011)' returned 24 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
Poland Insurance Market Intelligence: 2011 Edition
Koncept Analytics, Jan 2011 , Pages: 26Poland Insurance Market Intelligence: 2011 Edition Poland is Europe's 13th largest non-life insurance market (excluding the UK) and the most developed market for life insurance in the CEE region. The ... -
Poland Insurance Report Q1 2013
Business Monitor International, Dec 2012 , Pages: 86players in the segment have benefited. The obvious implication is that Polish households have regained an appetite for risk, with the result that life insurance's importance as a conduit for organised ... -
Private Equity in Poland 2011: Growth and Investment Opportunities
Monaco Research Partners (MRP), Oct 2011 , Pages: 32Private Equity in Poland 2011: Growth and Investment Opportunities Poland boasts a large domestic consumer market and rising domestic demand, being the only EU country not to go into recession during ... -
Poland Pharmaceuticals and Healthcare Report Q3 2011
Business Monitor International, May 2011 , Pages: 98Poland Pharmaceuticals and Healthcare Report Q3 2011 The Poland Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ... -
The Pharmaceutical Market: Serbia
Espicom Business Intelligence Ltd, May 2012 , Pages: 44of the highest growth rates in the region, similar to Poland or Romania. The market is driven by strong import growth, although a massive decline was recorded in 2009. Economic recovery will help to ... -
Poland Pharmaceuticals and Healthcare Report Q2 2012
Business Monitor International, Mar 2012 , Pages: 103Poland Pharmaceuticals and Healthcare Report Q2 2012 BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe ... -
Prefabricated Housing - Global Strategic Business Report
Global Industry Analysts, Inc, Feb 2013 , Pages: 334accounts for around 10% of the single-housing starts in the US. Shipments of manufactured homes witnessed an increase in 2011, a sharp relief to the slump witnessed in previous years. The continuing gloomy ... -
Poland Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009 , Pages: 82pharmaceuticals and healthcare industry. Poland is one of the highest value markets in Central and Eastern Europe (CEE) and as a result is a destination for almost all multinationals operating within the region ... -
Audiological Devices - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2012 , Pages: 442Market Drivers II-3 World Hearing Loss Prevalence II-3 A Snapshot of Global Hearing Loss Statistics II-4 Table 1: World Moderate-to-Severe Hearing Impaired Population for Years 2006 through 2015 ... -
Speciality Tourism - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 189Medical Tourists Expenditure (in US$ Billion) for the Years 2011 & 2012 50 Outbound Medical Tourism: Inevitable Growth 50 Table 8: US Outbound Medical Tourism Market: Flow of Outbound Patients (in ... -
Brazil Insurance Report Q1 2011
Business Monitor International, Nov 2010 , Pages: 77Brazil Insurance Report Q1 2011 Brazil Insurance Report provides industry professionals and strategists, corporate analysts, insurance associations, government departments and regulatory bodies with ... -
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and ... -
Egypt Insurance Report Q1 2011
Business Monitor International, Jan 2011 , Pages: 72Egypt Insurance Report Q1 2011 Business Monitor International's Egypt Insurance Report provides industry professionals and strategists, corporate analysts, insurance associations, government ... -
Catheter Markets
TriMark Publications, Jun 2012 , Pages: 3815: A Snapshot of Medical Device Industry, Based on a Survey by Professionals Appendix 5.1: Change in Domestic Sales in 2011 Appendix 5.2: Companies Seeking Outside Opportunities for Medical Devices ... -
Czech Republic Pharmaceuticals and Healthcare Report Q2 2011
Business Monitor International, Apr 2011 , Pages: 97drugmakers. Headline Expenditure Projections Pharmaceuticals: CZK80.30bn (US$4.23bn) in 2010 to CZK84.13bn (US$4.67bn) in 2011; +4.8% in local currency terms and +10.5% in US dollar terms. Forecast down ... -
Czech Republic Pharmaceuticals and Healthcare Report Q4 2011
Business Monitor International, Oct 2011 , Pages: 101drugmakers. Headline Expenditure Projections - Pharmaceuticals: CZK80.57bn (US$4.24bn) in 2010 to CZK82.04bn (US$4.82bn) in 2011; +1.8% in local currency terms and +14.3% in US dollar terms. Forecast in ... -
Slovakia Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Jan 2012 , Pages: 86: EUR1.68bn (US$2.22bn) in 2010 to EUR1.75bn (US$2.50bn) in 2011: +4.2% in local currency terms and +12.3% in US dollar terms. Forecast unchanged from Q411. - Healthcare: EUR5.53bn (US$7.33bn) in 2010 to ... -
Hungary Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 100achieved. Headline Expenditure Projections: - Pharmaceuticals: HUF678bn (US$3.27bn) in 2010 to HUF696bn (US$3.74bn) in 2011; +2.6% in local currency terms and +14.3% in US dollar terms. Forecast ... -
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Jan 2012 , Pages: 85Projections - Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to CHF5.73bn (US$6.71bn) in 2011; -2.6% growth in local currency terms and +19.08% in US dollar terms. - Healthcare: CHF59.54bn (US$57.09bn) in ... -
Belarus Pharmaceuticals and Healthcare Report Q3 2010
Business Monitor International, Jul 2010 , Pages: 66pharmaceutical producers are bound by a renewed voluntary pricing accord extending price freezes from 2009 to the end of 2011. Pharmacies are subject to margin controls. Rather implausibly, the government claimed ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
